Urabe F, Muramoto K, Yanagisawa T, Fukuokaya W, et al. Changes in the treatment landscape of metastatic hormone-sensitive prostate 
cancer following approval of upfront androgen receptor signaling inhibitors: A 
multicenter study. Int J Urol 2024 Jul 19. doi: 10.1111/iju.15546.
PMID: 39031448
|   |  |  | 
